Preclinical evaluation of antisense <i>bcl</i>‐2 as a chemosensitizer for patients with gastric carcinoma

Abstract

Combination treatment with AS bcl-2 and anticancer drugs, including cisplatin and TXL, may be a new strategy for enhancing chemotherapeutic effects in the treatment of gastric carcinoma.